{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:27:30Z","timestamp":1760236050376,"version":"build-2065373602"},"reference-count":38,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>(1) Background: The aim of this study was to assess the outcomes for patients who underwent total colectomy (TC) as a part of surgery for ovarian cancer (OC). (2) Methods: We performed a retrospective analysis of 1636 OC patients. Residual disease (RD) was reported using Sugarbaker\u2019s completeness of cytoreduction score. (3) Results: Forty-two patients underwent TC during primary debulking surgery (PDS), and four and ten patients underwent TC during the interval debulking surgery (IDS) and secondary cytoreduction, respectively. The median overall survival (mOS) in OC patients following the PDS was 45.1 months in those with CC-0 (21%) resection, 11.1 months in those with CC-1 (45%) resection and 20.0 months in those with CC-2 (33%) resection (p = 0.28). Severe adverse events were reported in 18 patients (43%). In the IDS group, two patients survived more than 2 years after IDS and one patient died after 28.6 months. In the recurrent OC group, the mOS was 6.9 months. Patient age above 65 years was associated with a shortened overall survival (OS) and the presence of adverse events. (4) Conclusions: TC as a part of ultra-radical surgery for advanced OC results in high rates of optimal debulking. However, survival benefits were observed only in patients with no macroscopic disease.<\/jats:p>","DOI":"10.3390\/curroncol28050358","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T23:13:32Z","timestamp":1634598812000},"page":"4223-4233","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Total Colectomy as a Part of Ultra-Radical Surgery for Ovarian Cancer\u2014Short- and Long-Term Outcomes"],"prefix":"10.3390","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3313-7188","authenticated-orcid":false,"given":"Sebastian","family":"Szubert","sequence":"first","affiliation":[{"name":"2nd Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4758-9727","authenticated-orcid":false,"given":"Artur","family":"Skowyra","sequence":"additional","affiliation":[{"name":"2nd Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1385-6572","authenticated-orcid":false,"given":"Andrzej","family":"W\u00f3jtowicz","sequence":"additional","affiliation":[{"name":"Department of Artificial Intelligence, Faculty of Mathematics and Computer Science, Adam Mickiewicz University in Poznan, 61-614 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Pawlowicz","sequence":"additional","affiliation":[{"name":"2nd Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Szczepkowski","sequence":"additional","affiliation":[{"name":"Clinical Department of Colorectal, General and Oncological Surgery, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blazej","family":"Nowakowski","sequence":"additional","affiliation":[{"name":"Surgical, Oncology and Endoscopic Gynecology Department, The Greater Poland Center Cancer, 61-866 Poznan, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8575-0251","authenticated-orcid":false,"given":"Lukasz","family":"Wicherek","sequence":"additional","affiliation":[{"name":"2nd Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, 01-809 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3322\/caac.21456","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/gyno.1997.4890","article-title":"Analysis of failures after negative second-look in patients with advanced ovarian cancer: An Italian multicenter study","volume":"68","author":"Gadducci","year":"1998","journal-title":"Gynecol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/jnci\/djg036","article-title":"A Randomized Clinical Trial of Cisplatin\/Paclitaxel Versus Carboplatin\/Paclitaxel as First-Line Treatment of Ovarian Cancer","volume":"95","author":"Meier","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_4","first-page":"1234","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO)","volume":"15","author":"Reuss","year":"2009","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ygyno.2011.02.014","article-title":"Impact of a Structured Quality Management Program on Surgical Outcome in Primary Advanced Ovarian Cancer","volume":"121","author":"Harter","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1023\/A:1023791229361","article-title":"Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread","volume":"22","author":"Carmignani","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1369\/0022155417742897","article-title":"Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review","volume":"66","author":"Nieuwland","year":"2018","journal-title":"J. Histochem. Cytochem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ajog.2005.03.046","article-title":"Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: Implications regarding surgical management","volume":"193","author":"Hoffman","year":"2005","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygyno.2009.04.009","article-title":"Total colectomy as part of primary cytoreductive surgery in advanced M\u00fcllerian cancer","volume":"114","author":"Song","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000504538","article-title":"An Analysis of Long-Term Outcomes in Patients Treated by Extensive Bowel Resection Due to Advanced Ovarian Cancer Relative to the Effectiveness of Surgery","volume":"85","author":"Lepinay","year":"2019","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ygyno.2016.01.008","article-title":"Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center","volume":"140","author":"Mueller","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2020.07.009","article-title":"Ultra-radical upfront surgery does not improve survival in women with advanced epithelial ovarian cancer; a natural experiment in a complete population","volume":"159","author":"Falconer","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1200\/JCO.2014.56.3106","article-title":"Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: An analysis of GOG 182","volume":"10","author":"Horowitz","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Paul, H. (1996). Sugarbaker Peritoneal Carcinomatosis: Principles of Management, Kluwer Academic.","DOI":"10.1007\/978-1-4613-1247-5"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1159\/000366249","article-title":"Total or subtotal colectomy in patients undergoing surgery for primary or recurrent epithelial ovarian cancer","volume":"37","author":"Oseledchyk","year":"2014","journal-title":"Oncol. Res. Treat."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.21873\/invivo.12099","article-title":"Subtotal colectomy as part of debulking surgery for advanced-stage ovarian cancer","volume":"34","author":"Bacalbasa","year":"2020","journal-title":"In Vivo"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00404-016-4265-9","article-title":"The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer","volume":"295","author":"Turnbull","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_20","first-page":"487","article-title":"Total colectomy in primary ovarian cytoreduction","volume":"32","author":"Walter","year":"2011","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2009.05.037","article-title":"Extended left colon resections as part of complete cytoreduction for ovarian cancer: Tips and considerations","volume":"114","author":"Silver","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"209.e1","DOI":"10.1016\/j.ajog.2007.04.049","article-title":"Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection","volume":"197","author":"Hoffman","year":"2007","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.ejso.2013.08.013","article-title":"Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer","volume":"40","author":"Gil","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ygyno.2017.09.021","article-title":"Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer","volume":"147","author":"Torres","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","article-title":"Splenectomy as part of cytoreductive surgery in ovarian cancer","volume":"102","author":"Magtibay","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2019.05.013","article-title":"Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology\/GOG Ancillary study of 7914 patients","volume":"154","author":"Fuh","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): An open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/ijgc-2020-001640","article-title":"Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)","volume":"30","author":"Fagotti","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejca.2020.02.020","article-title":"Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III\/IV ovarian, tubal and peritoneal cancers in phase III randomised trial","volume":"130","author":"Onda","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chang, L.-C., Huang, C.-F., Lai, M.-S., Shen, L.-J., Wu, F.-L.L., and Cheng, W.-F. (2018). Prognostic factors in epithelial ovarian cancer: A population-based study. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0194993"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Joueidi, Y., Dion, L., Bendifallah, S., Mimoun, C., Bricou, A., NyangohTimoh, K., Collinet, P., Touboul, C., Ouldamer, L., and Aza\u00efs, H. (2020). Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051451"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1757-2215-6-42","article-title":"Treatment reality in elderly patients with advanced ovarian cancer: A prospective analysis of the OVCAD consortium","volume":"6","author":"Trillsch","year":"2013","journal-title":"J. Ovarian Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Dion, L., Mimoun, C., NyangohTimoh, K., Bendifallah, S., Bricou, A., Collinet, P., Touboul, C., Ouldamer, L., Aza\u00efs, H., and Dabi, Y. (2020). Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis\u2014A Study from the FRANCOGYN Group. J. Clin. Med., 9.","DOI":"10.3390\/jcm9051339"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/IGC.0b013e3181c10c04","article-title":"Primary radical surgery in elderly patients with epithelial ovarian cancer analysis of surgical outcome and long-term survival","volume":"20","author":"Fotopoulou","year":"2010","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-17-0246","article-title":"Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes","volume":"23","author":"Wang","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Ohsuga, T., Yamaguchi, K., Kido, A., Murakami, R., Abiko, K., Hamanishi, J., Kondoh, E., Baba, T., Konishi, I., and Matsumura, N. (2017). Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3573-1"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1200\/JCO.2020.38.15_suppl.6000","article-title":"Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III\/ENGOT-ov20","volume":"38","author":"Sehouli","year":"2020","journal-title":"J. Clin. Oncol."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/5\/358\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:17:34Z","timestamp":1760167054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/28\/5\/358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["curroncol28050358"],"URL":"https:\/\/doi.org\/10.3390\/curroncol28050358","relation":{},"ISSN":["1718-7729"],"issn-type":[{"type":"electronic","value":"1718-7729"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}